Huafang Li
- Biomaterials top 2%
- Materials Chemistry top 10%
- Mechanical Engineering top 5%
- Psychiatry and Mental health top 5%
- Molecular Biology
- Topics
- Schizophrenia research and treatment (27 papers)Tryptophan and brain disorders (12 papers)Treatment of Major Depression (10 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEBiomaterials
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Huafang Li
74 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 133
- Biomaterials 617
- Materials Chemistry 528
- Mechanical Engineering 408
- Psychiatry and Mental health 394
- Molecular Biology 356
Countries citing papers authored by Huafang Li
This map shows the geographic impact of Huafang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafang Li more than expected).
Fields of papers citing papers by Huafang Li
This network shows the impact of papers produced by Huafang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafang Li. The network helps show where Huafang Li may publish in the future.
Co-authorship network of co-authors of Huafang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Huafang Li. A scholar is included among the top collaborators of Huafang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafang Li. Huafang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 12 | |
| 7 | 24 | |
| 8 | 4 | |
| 9 | 5 | |
| 10 | 19 | |
| 11 | 184 | |
| 12 | 105 | |
| 13 | 79 | |
| 14 | 15 | |
| 15 | 20 | |
| 16 | 15 | |
| 17 | Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia | 0 |
| 18 | 84 | |
| 19 | 17 | |
| 20 | 26 |
About Huafang Li
Huafang Li is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Developmental Neuroscience, having authored 82 papers that have together received 2.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (27 papers), Tryptophan and brain disorders (12 papers) and Treatment of Major Depression (10 papers). The work is most often cited by research in Biological Psychiatry (162 citations), Biomaterials (617 citations) and Psychiatry and Mental health (394 citations). Huafang Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yufeng Zheng, Ling Qin, Kejin Qiu, Xiang Wang, Feiyu Zhou, Hongtao Yang, Niufan Gu, Yifeng Shen, Guoyin Feng and Qing Rui. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.